Find a Researcher
David Medina, PhD
Neurobiology
Originally from El Paso, Texas, Dr. Medina earned his PhD from the University of Texas Health Science Center in 2013. During this time, he worked in the laboratory of Salvatore Oddo, PhD, researching the molecular mechanisms of Alzheimer’s disease and frontotemporal lobar degeneration. His research interests included identifying the basic mechanisms and novel therapeutic candidates of neurodegenerative diseases.
Dr. Medina’s research focuses on developing better methods to target nanoparticles for drug delivery to regions of the central nervous system affected by neurodegenerative or neuromuscular diseases. His eventual goal is to deliver and evaluate new candidate drugs for the treatment of amyotrophic lateral sclerosis.
MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS
Date: 02/2023
Authors: Marissa Dominick, Nicole Houchins, Vinisha Venugopal, Aamir R. Zuberi, Cathleen M. Lutz, Bessie Meechooveet, Kendall Van Keuren-Jensen, Robert Bowser, David X. Medina
Longitudinal evaluation of myofiber microstructural changes in a preclinical ALS model using the transverse relaxivity at tracer equilibrium (TRATE): A preliminary study
Date: 01/2022
Authors: Laura C. Bell, Alberto E. Fuentes, Deborah R. Healey, Debbie R. Healey, Renee Chao, Nadine Bakkar, Rachael W. Sirianni, David X. Medina, Robert P. Bowser, Robert Bowser, Shafeeq S. Ladha, Natenael B. Semmineh, Ashley M. Stokes, C. Chad Quarles
Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (Nature Communications, (2020), 11, 1, (2612), 10.1038/s41467-020-15701-2)
Date: 12/2021
Authors: Jacob W. Vogel, Yasser Iturria-Medina, Olof T. Strandberg, Ruben Smith, Elizabeth Levitis, Alan C. Evans, Oskar Hansson, Michael Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Enchi Liu, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein, Nick Fox, Paul Thompson
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Date: 05/2021
Authors: Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, Ruben Smith, Rik Ossenkoppele, Olof T. Strandberg, Renaud La Joie, Leon M. Aksman, Michel J. Grothe, Yasser Iturria-Medina, Michael Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Enchi Liu, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein
Investigating cognition in midlife
Date: 01/2021
Authors: Jan S. Novotný, Juan P. Gonzalez-Rivas, Jose R. Medina-Inojosa, Francisco Lopez-Jimenez, Yonas E. Geda, Gorazd B. Stokin
- English
David Medina, PhD
Neurobiology
Originally from El Paso, Texas, Dr. Medina earned his PhD from the University of Texas Health Science Center in 2013. During this time, he worked in the laboratory of Salvatore Oddo, PhD, researching the molecular mechanisms of Alzheimer’s disease and frontotemporal lobar degeneration. His research interests included identifying the basic mechanisms and novel therapeutic candidates of neurodegenerative diseases.
Dr. Medina’s research focuses on developing better methods to target nanoparticles for drug delivery to regions of the central nervous system affected by neurodegenerative or neuromuscular diseases. His eventual goal is to deliver and evaluate new candidate drugs for the treatment of amyotrophic lateral sclerosis.
MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS
Date: 02/2023
Authors: Marissa Dominick, Nicole Houchins, Vinisha Venugopal, Aamir R. Zuberi, Cathleen M. Lutz, Bessie Meechooveet, Kendall Van Keuren-Jensen, Robert Bowser, David X. Medina
Longitudinal evaluation of myofiber microstructural changes in a preclinical ALS model using the transverse relaxivity at tracer equilibrium (TRATE): A preliminary study
Date: 01/2022
Authors: Laura C. Bell, Alberto E. Fuentes, Deborah R. Healey, Debbie R. Healey, Renee Chao, Nadine Bakkar, Rachael W. Sirianni, David X. Medina, Robert P. Bowser, Robert Bowser, Shafeeq S. Ladha, Natenael B. Semmineh, Ashley M. Stokes, C. Chad Quarles
Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (Nature Communications, (2020), 11, 1, (2612), 10.1038/s41467-020-15701-2)
Date: 12/2021
Authors: Jacob W. Vogel, Yasser Iturria-Medina, Olof T. Strandberg, Ruben Smith, Elizabeth Levitis, Alan C. Evans, Oskar Hansson, Michael Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Enchi Liu, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein, Nick Fox, Paul Thompson
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
Date: 05/2021
Authors: Jacob W. Vogel, Alexandra L. Young, Neil P. Oxtoby, Ruben Smith, Rik Ossenkoppele, Olof T. Strandberg, Renaud La Joie, Leon M. Aksman, Michel J. Grothe, Yasser Iturria-Medina, Michael Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John Morris, Leslie M. Shaw, Enchi Liu, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Devon Gessert, Tamie Sather, Gus Jiminez, Danielle Harvey, Matthew Bernstein
Investigating cognition in midlife
Date: 01/2021
Authors: Jan S. Novotný, Juan P. Gonzalez-Rivas, Jose R. Medina-Inojosa, Francisco Lopez-Jimenez, Yonas E. Geda, Gorazd B. Stokin
- English